Burimamide is a histamine H2 receptor antagonist that inhibits gastric acid secretion induced by pentagastrin (HY-A0261) or gastrin; it also exhibits α-adrenergic receptor blocking activity; in combination with the H1 receptor antagonist mepyramine (HY-B1281), burimamide demonstrates anti-inflammatory activity in a rat paw edema model induced by compound 48/80 (HY-115768).